Clinical Study
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia
Table 3
Nonhematological adverse events.
| | Toxicity | Number of patients (%) |
| | Liver toxicity (Grade 2) | 1 (4) |
| | Mucositis | | | (i) Grade 1 (mild) | 1 (4) | | (ii) Grade ≥ 2 (moderate-severe) | 2 (8) |
| | Cerebellar toxicity | 2 (8) |
| | Neutropenic fever | 10 (38) |
| | Infection | | | (i) Fungal pneumonia | 4 (15) | | (ii) Pneumonia, unknown pathogen | 1 (4) | | (iii) Bacteremia | 4 (15) | | (iv) Cellulitis | 1 (4) |
| | Skin toxicity | 2 (8) |
| | Other toxicities: nausea (1) and pericardial effusion (n = 1) |
|
|